- Home
- ZYME vs RVT Comparison
ZYME vs RVT Comparison
Compare ZYME & RVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | RVT |
|---|---|---|
| Founded | 2003 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZYME | RVT |
|---|---|---|
| Price | $27.00 | $18.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $38.90 | N/A |
| AVG Volume (30 Days) | ★ 522.6K | 199.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.32% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ 2.95 |
| Revenue | ★ $105,965,000.00 | N/A |
| Revenue This Year | $180.13 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.06 |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $10.69 | $13.00 |
| 52 Week High | $28.49 | $18.73 |
Technical Indicators
Market Signals| Indicator | ZYME | RVT |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | 65.79 |
| Support Level | $22.28 | $15.79 |
| Resistance Level | $27.35 | $18.70 |
| Average True Range (ATR) | 1.04 | 0.42 |
| MACD | 0.18 | 0.21 |
| Stochastic Oscillator | 91.56 | 95.51 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About RVT Royce Value Trust Inc.
Royce Small-Cap Trust Inc is a diversified closed-end investment company that invests in equity securities of small-cap companies. The company portfolio includes sectors such as Industrials, Financials, Information Technology, Health Care, and Consumer Discretionary.